Clinical study to evaluate the role of leech therapy in keloid

Randomized controlled clinical trial to evaluate the efficacy of Jalaukavacharana in the management of Vranagranti Keloid - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103392

Enrollment

Registered

2026-02-09

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: PCS-

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: The patients of age group between 20 to 60 years irrespective of gender Patients clinically diagnosed with Vranagranti Keloid

Exclusion criteria

Exclusion criteria: Infected inflamed or ulcerated keloids Allergy to leech saliva or corticosteroids Bleeding disorders uncontrolled hypertension diabetes or immunocompromised status

Design outcomes

Primary

Measure	Time frame
Change in pain itching and burning sensation assessed using Visual Analogue Scale and change in size colour and hardness of keloid assessed clinically from baseline to end of treatmentTimepoint: 28 days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Khushboo Rajesh Katariya

CSMSS Ayurved Mahavidyalaya And Rugnalaya

drgadvekayakalp@gmail.com9822682898

Outcome results